Home » Radiopharm Theranostics: Developing Innovative Radiopharmaceuticals for a Highly Underserved Oncology Sector

Radiopharm Theranostics: Developing Innovative Radiopharmaceuticals for a Highly Underserved Oncology Sector

Radiopharm Theranostics: Developing Innovative Radiopharmaceuticals for a Highly Underserved Oncology Sector

Radiopharm’s clinical stage development in the pipeline include:

This Radiopharm Theranostics profile is part of a paid investor education campaign.*

source

Leave a Reply

Your email address will not be published.